Share this article

print logo


Good news, migraine sufferers: The Food and Drug Administration has approved a new nasal spray for treating the terrible headaches, maker Glaxo Wellcome PLC says. Glaxo will start marketing the spray version of Imitrex, also known as Imigran, this month. The drug is already available in pill form and home-injection kits, but a Glaxo spokeswoman says the nasal spray is both quicker and more appropriate for some people.

There are no comments - be the first to comment